One-off tweets do not fix the systemic problems we have with drug prices. We need long-term structural action to provide enduring relief.
Vertex Brags About Sitting On More Than $2 Billion Cash But Refuses To Reduce Prices As Patients Suffer.
Patient Advocates to raise the issue of drug prices during discussions about non-communicable diseases.
July brought warm weather and new price hikes for Americans already struggling under unfair list prices.
Medicare spent nearly $2 billion on H.P. Acthar Gel from 2011-2016, according to the agency's data — even though some doctors say an equally effective treatment would have cost a tiny fraction of that amount
My name is April. I live and work in Pensacola, Florida with my wonderful husband and our 11-year-old son. I also have incurable breast cancer.
Receiving assistance from a drug corporation to afford an expensive prescription feels a lot like pharma benevolence. Here's why these programs are robbing us blind: